Eksempel: Heart Attack

Søk i kliniske studier for: Keyhole-limpet hemocyanin

Totalt 47 resultater

NCT01509391

Fullført

Keyhole Limpet Hemocyanin in Chronic Hepatitis C

Forhold: Chronic Hepatitis C; Liver Cirrhosis
NCT00006034

Fullført

Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer

Forhold: Bladder Cancer
NCT00470574

Fullført

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Forhold: Breast Cancer
NCT01489956

Avsluttet

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Forhold: Autoimmune Disorders
NCT00026624

Fullført

Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC

Forhold: HIV Infections
NCT00369291

Avsluttet

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Forhold: Germ Cell Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
NCT00614731

Fullført

Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

Forhold: Atopic Dermatitis
NCT02079480

Avsluttet

Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects

Forhold: Healthy Adult Volunteers
NCT00536120

Fullført

The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

Forhold: Multiple Sclerosis
NCT00019097

Fullført

Vaccine Therapy in Treating Patients With Multiple Myeloma

Forhold: Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
NCT01910662

Fullført

Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)

Forhold: Dermatitis
NCT00004249

Fullført

Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy

Forhold: Lung Cancer
NCT00050921

Fullført

Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs

Forhold: HIV Infections
NCT00000105

Avsluttet

Vaccination With Tetanus and KLH to Assess Immune Responses.

Forhold: Cancer
NCT00003819

Fullført

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Forhold: Prostate Cancer
NCT00004198

Fullført

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Forhold: Lymphoma
NCT00004156

Fullført

Vaccine Therapy in Treating Patients With Breast Cancer

Forhold: Breast Cancer
NCT00006478

Avsluttet

Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Forhold: Lymphoma
NCT00003638

Fullført

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Forhold: Breast Cancer
NCT02947854

Fullført

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Forhold: Healthy Volunteer
NCT02754362

Tilbaketrukket

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Forhold: Glioblastoma; Glioma
NCT02745756

Tilbaketrukket

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Forhold: Neuroblastoma; Neoplasms, Nerve Tissue
NCT00093522

Ukjent status

Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer

Forhold: Kidney Cancer
NCT01082198

Ukjent status

Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

Forhold: Melanoma (Skin)
NCT00030823

Fullført

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Forhold: Breast Cancer